Taiwan's National Health Insurance (NHI) system has approved its first-ever patient to receive a one-time NT$49 million (US$1.53 million) drug for spinal muscular atrophy (SMA), which was added to a list of covered treatments earlier this month, an official said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
China to lift ban on Taiwan fish, citrus fruit: Chinese official
04/28/2024 09:21 PM - Society
More rain forecast throughout Taiwan from Wednesday
04/28/2024 09:10 PM - Society
Kaohsiung mayor pays tribute to search and rescue dogs, handlers
04/28/2024 08:55 PM - Society
Black pepper recalled in New Taipei due to dye contamination
04/28/2024 08:12 PM - Cross-Strait
Taiwan lukewarm about China's eased rules on travel to Matsu
04/28/2024 06:16 PM